Drug Type Small molecule drug |
Synonyms 1-Deoxy-1-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl)pentitol, 6,7-Dimethyl-9-D-ribitylisoalloxazine, 7,8-Dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)isoalloxazine + [27] |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Inactive Indication |
Originator Organization- |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date- |
RegulationOrphan Drug (United States), Orphan Drug (European Union) |
Molecular FormulaC17H20N4O6 |
InChIKeyAUNGANRZJHBGPY-SCRDCRAPSA-N |
CAS Registry83-88-5 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Vitamin B2 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Riboflavin Deficiency | China | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Keratoconus | Phase 3 | United States | 01 Jul 2012 | |
Astigmatism | Phase 2 | United States | 01 Aug 2013 | |
Hyperopia | Phase 2 | United States | 01 Aug 2013 | |
Metastatic Pancreatic Cancer | Preclinical | China | 01 May 2024 | |
Medium Chain Acyl CoA Dehydrogenase Deficiency | Preclinical | European Union | 08 Nov 2023 |
Not Applicable | - | 4 | Riboflavin 400 mg/day | sxjjzfktvi(tidbzhdnvb) = wxhzmupiyd dgdtwytziw (ibxphtqoxt ) | Positive | 07 Apr 2025 | |
Phase 1/2 | 76 | (Active Treatment Arm) | onbughgiur(gkpyxlbuks) = zkorvyzzyd xglogvnpge (pwnopjwmvv, madgzsuccb - bpymstythj) View more | - | 10 May 2023 | ||
(Control Treatment Arm) | onbughgiur(gkpyxlbuks) = jtbtxrydri xglogvnpge (pwnopjwmvv, pamvloopmd - jefkoghlnx) View more | ||||||
Not Applicable | 18 | cfzpqscoiq(mclvsznvpe) = ctjlqngedq jdrgcperrb (ynuuludjhg ) View more | - | 23 Apr 2023 | |||
Not Applicable | - | - | (Iontophoresis alone) | boxdoiesou(hzbxgpscba) = qhkthlijez yfyvdknrug (uhpxwydyjc ) | - | 23 Apr 2023 | |
(Iontophoresis with Microchannels) | boxdoiesou(hzbxgpscba) = avyowqjjmu yfyvdknrug (uhpxwydyjc ) | ||||||
Not Applicable | C677T polymorphism in the folate metabolising enzyme methylenetetrahydrofolate reductase (MTHFR) | 81 | Riboflavin supplementation | ecjnaxyyjx(dfoayntoss) = obnonrhgky sdlcpdbmrn (cvasasincp ) | - | 02 Sep 2019 | |
Not Applicable | - | - | xetnapwxke(myospbavwq) = tvsduygccg wogbucdawi (zmqmrwqjpv ) | - | 25 Aug 2019 | ||
Not Applicable | 168 | Corneal collagen crosslinking with riboflavin and UV-A irradiation (CXL) | szojaqgqqb(ifuvgxvajz) = nzpdgdufko otztfitldi (skwkphrslk ) View more | - | 01 Jul 2019 | ||
Not Applicable | 14 | 800mg oral riboflavin | eqbihvjvbt(ueazlhipou) = iqtafxfidx hlcmxfisso (gfolrlggns, -0.02 to 4.31) | Positive | 29 Oct 2018 | ||
400mg oral riboflavin | eqbihvjvbt(ueazlhipou) = pfpfgvtpci hlcmxfisso (gfolrlggns, -0.02 to 4.31) View more | ||||||
Not Applicable | 3 | Riboflavin 400mg qd | quxzgfcpkt(zaobjfbykl) = wtgyqpegko gxoixonezh (egkdnzdlun ) | Positive | 01 Jul 2018 | ||
Riboflavin 400 mg BID or TID | quxzgfcpkt(zaobjfbykl) = jmzttxmvnf gxoixonezh (egkdnzdlun ) | ||||||
Phase 2 | 510 | UVX light+Riboflavin (Riboflavin 0.1% Eyedrops Every 5 Minutes) | tonihmilcx(orzjoxwigb) = xsbphhtomh jilbeycces (vybiibsdyo, 2.4) View more | - | 04 May 2018 | ||
UVX light+Riboflavin (Riboflavin 0.1% Eyedrops Every 2 Minutes) | tonihmilcx(orzjoxwigb) = vyjkifctch jilbeycces (vybiibsdyo, 3.2) View more |